Page 15 - SAMRC Annual Report 2024-2025

GENERAL INFORMATION

in human studies on these products and highlight Preparedness Secretariat (IPPS) and the National
the potential of traditional healer – academia Department of Health in January 2025 to launch the
collaboration. Additionally, the SAMRC continues 4th Implementation Report of the 100 Days Mission
to fund smaller grants in the IKS and phytomedicine (100DM), an initiative aimed at ensuring global
arena through its self-initiated research and capacity access to diagnostics, therapeutics, and vaccines
development initiatives. (DTVs) within 100 days of a Public Health Emergency
of International Concern. The report, unveiled at an
The benefits of scientific validation of plant-based event co-hosted by IPPS, the National Department
medicines extend beyond health and include the of Health and SAMRC in Cape Town, highlights that
potential for economic empowerment and job while there have been bright spots at a national
creation that will improve the overall well-being of level, the world remains insufficiently prepared for a
rural communities. 100-day response to a future pandemic. The report
is accompanied by the 2nd iteration of the 100DM
Launch of the 100 Day Mission Report in
scorecard which shows that critical gaps remain,
Partnership with IPPS and the NDOH particularly in the development and deployment
Pandemic preparedness is one of SAMRC’s key of diagnostics and therapeutics for diseases with
priorities following the COVID-19 pandemic and pandemic potential. As the world continues to
more recent outbreaks of Mpox, H5N1, cholera, and grapple with evolving threats, the report underscores
other pathogens of concern. As such, the SAMRC was the urgency of building a robust and equitable R&D
honoured to partner with the International Pandemic ecosystem.

CTO's

Preclinical Phase 1 Phase 2/3 Product Commercial
Tax Clinical Trial Clinical Trials Registration Manufacture

science & innovation
Department:
Science and Innovation
REPUBLIC OF SOUTH AFRICA

SAMRC ANNUAL REPOR T 2024-25 13